Original article
Aktuell steht das AMNOG mit seinen Auswirkungen auf die Versorgung von Patienten mit innovativen Präparaten im Fokus des Arzneimittelmarktes. Am Ende des Lebenszyklus einer pharmazeutischen Innovation finden sich allerdings ebenfalls aktuelle Themen von hoher Relevanz für die Patientenversorgung, die vielleicht etwas weniger im Rampenlicht stehen. Gemeint ist der Ablauf des Patents und dessen Folgen. > […]
23.06.2012
Im Management von Ärztenetzen geht es nach der vorliegenden Literatur ganz besonders darum, die vorhandene Versorgung zu verbessern. Bestehende Behandlungsabläufe sind optimaler und wirtschaftlicher durchzuführen. Sei es, um das zeitliche Engagement von Ärzten zu reduzieren, um Bürokratie abzubauen, um Wirtschaftlichkeitsreserven auszuschöpfen oder sich im Markt gegenüber anderen Anbietern zu verteidigen. Gerade Kostenträger fordern von Ärztenetzen […]
15.04.2012
Die medikamentöse Therapie des Diabetes mellitus Typ 2 hat sich in den vergangenen Jahren gewandelt. Signifikante Ausgabenanstiege, vor allem getrieben von moderneren Therapieansätzen wie den DPP-IV-Inhibitoren, waren kontinuierlich zu verzeichnen. 2011 wurde bereits jeder zweite Euro bei den oralen Antidiabetika (OAD) für DPP-IV-Hemmer aufgewendet. Doch das Marktwachstum könnte ins Stocken geraten. >> Diabetes mellitus Typ […]
01.04.2012
Versorgungsstrukturen auf dem Land flexibler zu gestalten, das hat sich die Bundesregierung mit dem am 1. Januar dieses Jahres in Kraft getretenen Versorgungsstrukturgesetz (GKV-VStG) vorgenommen. Dazu gehören sowohl eine zielgenauere Bedarfsplanung als auch eine verbesserte Verzahnung zwischen ambulantem und stationärem Sektor, wie Bundesgesundheitsminister Daniel Bahr in seinem Grußwort zum Fachkongress „Versorgung 2.0“ erklärte. Der erneut […]
01.04.2012
Literature research on the topic of “risks in health services research” is not fruitful because the topic has obviously only rarely been addressed so far. In order to differentiate the risks of health services research from the risks of other forms of research, we assume - in addition to the definitions of health services research offered so far (1) - that the primary goals of research and care are fundamentally different. In a traditional research project, the primary goal is to gain knowledge, while in a care project the primary interest is to provide the best possible care without the aim of gaining new knowledge at the same time. When this concept of the primary goals of research and care is applied, health care research projects are characterized by the combination of both goals.
27.02.2012
Literature research on the topic of “risks in health services research” is not fruitful because the topic has obviously only rarely been addressed so far. In order to differentiate the risks of health services research from the risks of other forms of research, we assume - in addition to the definitions of health services research offered so far (1) - that the primary goals of research and care are fundamentally different. In a traditional research project, the primary goal is to gain knowledge, while in a care project the primary interest is to provide the best possible care without the aim of gaining new knowledge at the same time. When this concept of the primary goals of research and care is applied, health care research projects are characterized by the combination of both goals.
27.02.2012
Cultural and epidemiological differences between Turkish and German patients with type 2 diabetes lead to inadequate healthcare provision for migrants of Turkish origin in Germany. Due to the current lack of care for migrants of Turkish origin (Robert Koch Institute 2008, p. 101; Aumiller 2009, p. 13; Icks et al. 2009, p. 132), the largest ethnic minority in Germany, there is a need for diabetes education programs tailored to the specific needs of this patient group. The aim of this pilot study was therefore to evaluate the innovative diabetes education program "Conversation Map©" in Turkish, which is specifically designed for the needs of this migrant group with type 2 diabetes. The joint project, entitled "Understanding Diabetes Together," was implemented in collaboration with Novitas BKK.
27.02.2012
Literature research on the topic of “risks in health services research” is not fruitful because the topic has obviously only rarely been addressed so far. In order to differentiate the risks of health services research from the risks of other forms of research, we assume - in addition to the definitions of health services research offered so far (1) - that the primary goals of research and care are fundamentally different. In a traditional research project, the primary goal is to gain knowledge, while in a care project the primary interest is to provide the best possible care without the aim of gaining new knowledge at the same time. When this concept of the primary goals of research and care is applied, health care research projects are characterized by the combination of both goals.
27.02.2012
Breast cancer is the most common type of cancer in women. In Germany, approximately 71,600 women were diagnosed with breast cancer in 2008; around 17,000 died from it (1). This corresponds to approximately 30% of new cancer cases and 15% of deaths (2). In recent years there have been significant advances in the treatment of breast cancer. Today, thanks to improved surgical methods and modern medications, the majority of patients can be cured. In order to reduce the risk of recurrence, patients affected by carcinoma are usually prescribed adjuvant therapy with tamoxifen or aromatase inhibitors for a period of five years. The active ingredient tamoxifen has proven itself in adjuvant therapy after surgical tumor removal in premenopausal patients. It is considered a standard medication for antihormone therapy and reduces the number of breast cancer relapses by half (3, 4). Aromatase inhibitors are a treatment option that is mainly used in postmenopausal women. According to many studies, aromatase inhibitors are superior in use to tamoxifen (5-8).
27.02.2012
Despite significant advances in diabetes therapy, patients with type 2 diabetes have an increased risk of developing cardiovascular complications (1,2). In cases of inadequate metabolic control under non-pharmacological measures and oral antidiabetic treatment, early initiation of insulin therapy is therefore recommended (3). Among short-acting insulins, the analog insulin glulisine is characterized by particularly rapid and high absorption from the subcutaneous tissue (4). Compared to short-acting human insulin (regular insulin), glulisine has been shown to reduce postprandial blood glucose elevations more effectively and to normalize postprandial microcirculation more rapidly (5). Antidiabetic treatments aimed at influencing postprandial glucose excursions also have a positive impact on clinical parameters of coronary heart disease and its consequences (6,7). However, there are currently no prospective data on the effects of short-acting insulins on the risk of cardiovascular complications in type 2 diabetes. This raises the question of whether the pharmacological advantages of glulisine have an impact on the occurrence of cardiovascular complications compared to regular insulin under real-world care conditions.